Genotyping, quality control (QC), and imputation were performed centrally by UKBB, and details are fully described elsewhere (79 (link)). Briefly, genotype data are available for 488,377 individuals, 49,950 of whom were genotyped using the Applied Biosystems U.K. BiLEVE Axiom Array by Affymetrix [containing 807,411 markers (81 (link))]. The remaining 438,427 individuals were genotyped using the Applied Biosystems U.K. Biobank Axiom Array by Affymetrix (containing 825,927 markers). Both arrays were specifically designed for use in the UKBB project and share ~95% of marker content. Phasing was performed using SHAPEIT3, and imputation was conducted using IMPUTE4. For imputation, the Haplotype Reference Consortium (HRC) panel (82 (link)) was used wherever possible, and for SNPs not in that reference panel, a merged UK10K + 1000 Genomes reference panel was used. SNPs were imputed from both panels, but the HRC imputation was preferentially used for SNPs present in both panels. Both SNPs selected as instruments in this study demonstrated high imputation quality in UKBB (info scores of 0.98 and 0.95 for rs7209826 and rs188810925, respectively).